Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Clinical trial NCT05874635 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05874635
Sponsor: Signos Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Weight Loss Metabolic Syndrome Diabetes Mellitus, Type 2 Central Obesity Insulin Resistance Glucose Intolerance Metabolic Glucose Disorders

Start date: 2023-05-11
Primary completion: 2028-05-10
Enrollment: 20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.